EFFICACY OF KARXT ON NEGATIVE SYMPTOMS IN ACUTE SCHIZOPHRENIA: AN ANALYSIS OF POOLED DATA FROM 3 TRIALS

被引：0
|
作者：
Vuocolo, Scott [1 ]
Horan, William P. [1 ]
Claxton, Amy [1 ]
Targum, Steven D. [2 ]
Kaul, Inder [1 ]
Sawchak, Sharon [1 ]
Miller, Andrew C. [1 ]
Paul, Steven M. [1 ]
Brannan, Stephen K. [1 ]
机构：
[1] Karuna Therapeut, Boston, MA USA
[2] Signant Hlth, Boston, MA USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2025年 / 28卷
关键词：
KarXT; muscarinic receptors; negative symptoms; schizophrenia; xanomeline;
D O I：
10.1093/ijnp/pyae059.636
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
pyae059.63
引用
收藏
页码：358 / 359
页数：2
相关论文
共 50 条
  • [31] Defining and measuring negative symptoms of schizophrenia in clinical trials
    Marder, Stephen R.
    Kirkpatrick, Brian
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 (05) : 737 - 743
  • [32] NEGATIVE SYMPTOMS IN SCHIZOPHRENIA - CONSIDERATIONS FOR CLINICAL-TRIALS
    MOLLER, HJ
    VANPRAAG, HM
    AUFDEMBRINKE, B
    BAILEY, P
    BARNES, TRE
    BECK, J
    BENTSEN, H
    EICH, FX
    FARROW, L
    FLEISCHHACKER, WW
    GERLACH, J
    GRAFFORD, K
    HENTSCHEL, B
    HERTKORN, A
    HEYLEN, S
    LECRUBIER, Y
    LEONARD, JP
    MCKENNA, P
    MAIER, W
    PEDERSEN, V
    RAPPARD, A
    REIN, W
    RYAN, J
    NIELSEN, MS
    STIEGLITZ, RD
    WEGENER, G
    WILSON, J
    PSYCHOPHARMACOLOGY, 1994, 115 (1-2) : 221 - 228
  • [33] Cariprazine vs risperidone efficacy on predominant negative symptoms of schizophrenia: post hoc analysis of negative symptoms subdomains
    Laszlovszky, I.
    Barabassy, A.
    Szatmari, B.
    Harsanyi, J.
    Szalai, E.
    Nemeth, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S902 - S903
  • [34] Remission in acute mania: pooled data from two aripiprazole trials
    Dogin, J
    Sanchez, R
    Stringfellow, J
    Yamamoto, Y
    Carson, WH
    BIPOLAR DISORDERS, 2005, 7 : 49 - 49
  • [35] Remission in acute mania: Pooled data from two aripiprazole trials
    Griffiths, LA
    Dogin, J
    Carlson, B
    Sanchez, R
    Carson, W
    Marcus, R
    Stringfellow, J
    McQuade, R
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2005, 39 : A134 - A135
  • [36] Efficacy of lurasidone in schizophrenia: pooled analysis of the five PANSS factors in short-term trials
    Werner, P.
    Cucchiaro, J.
    Silva, R.
    Pikalov, A.
    Mao, Y.
    Loebel, A.
    Marder, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S341 - S341
  • [37] Efficacy and Safety of Lumateperone 42 Mg in the Treatment of Schizophrenia: A Pooled Analysis of Randomized Clinical Trials
    Vanover, Kimberly
    Kane, John
    Satlin, Andrew
    Durgam, Suresh
    Davis, Robert
    Mates, Sharon
    Tamminga, Carol
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 492 - 493
  • [38] EFFICACY OF ILOPERIDONE IN EARLY-STAGE SCHIZOPHRENIA: RESULTS FROM A POOLED ANALYSIS OF 4 PHASE III CLINICAL TRIALS
    Kane, John M.
    Hochfeld, M.
    Meng, X.
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 308 - 308
  • [39] Efficacy of topiramate for the prevention of migraine in patients reporting symptoms of aura or migraine without aura: Pooled data from 3 placebo-controlled trials
    Pascual, J.
    Silberstein, S.
    Mao, L.
    Greenberg, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 76 - 76
  • [40] Efficacy of topiramate for the prevention of migraine in patients reporting symptoms of aura or migraine without aura: Pooled data from 3 placebo-controlled trials
    Silberstein, S
    Pascual, J
    Mao, L
    Greenberg, S
    HEADACHE, 2005, 45 (06): : 824 - 824
12345